Skip to main navigation
logo

Site - Investor Relations

  • Overview
  • News & Events
    • Press Releases
    • Events
    • Presentations
  • Stock Information
    • Stock Quote & Chart
  • Corporate Governance
    • Documents & Charters
    • Leadership Team
    • Board of Directors
    • Committee Composition
    • Contact the Board
  • Financials & Filings
    • SEC Filings
    • Annual Reports
    • Quarterly Results
  • IR Resources
    • FAQs
    • Email Alerts
    • Contact IR

Press Releases

May 12, 2022 - Zymergen Reports Preliminary First Quarter 2022 Financial Results
PDF Version
April 29, 2022 - Zymergen to Participate in the BofA Securities 2022 Healthcare Conference
PDF Version
April 13, 2022 - Zymergen to Report Preliminary First Quarter 2022 Financial Results on May 12, 2022
PDF Version
March 22, 2022 - Zymergen Reports Preliminary Fourth Quarter and Full Year 2021 Financial Results
PDF Version
March 16, 2022 - Zymergen to Report Preliminary Fourth Quarter and Full Year 2021 Financial Results on March 22nd, 2022
PDF Version
March 6, 2022 - Zymergen Advances Molecules for Prominent Malaria and COVID-19 Drug Targets for Further Testing
PDF Version
February 28, 2022 - Zymergen to Participate in the 42nd Annual Cowen Healthcare Conference
PDF Version
January 10, 2022 - Zymergen Debuts Automation Business and Shares Program Portfolio at 40th Annual JP Morgan Healthcare Conference
PDF Version
January 9, 2022 - Zymergen Announces Emerging Drug Discovery Business Enabled by One of the World’s Largest Metagenomics Databases and Proprietary Synthetic Biology Platform
PDF Version
January 5, 2022 - Zymergen to Present at the 40th Annual J.P. Morgan Healthcare Conference
PDF Version

Site - Shareholder Tools

  • Print Page
  • Email Alerts
  • RSS Feeds
  • Contact IR

© 2022 Zymergen.     All rights reserved.